Skip to Main Content


Cystic fibrosis (CF) is a monogenic disorder that presents as a multisystem disease. The first signs and symptoms typically occur in childhood, but about 5% of patients in the United States are diagnosed as adults. Due to improvements in therapy, >46% of patients are now adults (≥18 years old) and 16.4% are past the age of 30. The median survival is >37.4 years for patients with CF; thus, CF is no longer only a pediatric disease, and internists must be prepared to recognize and treat its many complications. CF is characterized by chronic bacterial infection of the airways that leads to bronchiectasis and bronchiolectasis, exocrine pancreatic insufficiency and intestinal dysfunction, abnormal sweat gland function, and urogenital dysfunction.


Genetic Considerations


CF is an autosomal recessive disease resulting from mutations in the CFTRgene located on chromosome 7. The mutations in the CFTR gene fall into five major classes, as depicted in Fig. 259-1. Classes I–III mutations are considered "severe," as indexed by pancreatic insufficiency and high sweat NaCl values (see below). Class IV and V mutations can be "mild," i.e., associated with pancreatic sufficiency and intermediate/normal sweat NaCl values.

Figure 259-1
Graphic Jump Location

Schema describing classes of genetic mutations in CFTR gene and effects on CFTR protein/function. Note the ΔF508 mutation is a class II mutation and, like class I mutations, would be predicted to produce no mature CFTR protein in the apical membrane. CFTR, cystic fibrosis transmembrane conductance regulator.


The prevalence of CF varies with the ethnic origin of a population. CF is detected in approximately 1 in 3000 live births in the Caucasian population of North America and northern Europe, 1 in 17,000 live births of African Americans, and 1 in 90,000 live births of the Asian population of Hawaii. The most common mutation in the CFTRgene (~70% of CF chromosomes) is a 3-bp deletion (a class II mutation) that results in an absence of phenylalanine at amino acid position 508 (ΔF508) of the CF gene protein product, known as cystic fibrosis transmembrane conductance regulator (CFTR). The large number (>1500) of relatively uncommon (<2% each) mutations identified in the CFTR gene makes genetic testing challenging.


CFTR Protein


The CFTR protein is a single polypeptide chain, containing 1480 amino acids, that functions both as a cyclic AMP–regulated Cl channel and a regulator of other ion channels. The fully processed form of CFTR localizes to the plasma membrane in normal epithelia. Biochemical studies indicate that the ΔF508 mutation leads to improper maturation and intracellular degradation of the mutant CFTR protein. Thus, absence of CFTR in the plasma membrane is central to the molecular pathophysiology of the ΔF508 mutation and other classes I–II mutations. Classes III–IV mutations produce CFTR proteins that are fully processed but are nonfunctional or only partially functional ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessPharmacy Full Site: One-Year Subscription

Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessPharmacy

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.